Pioneering the Future of Compound Testing

Shaping Tomorrow's Medicine

By replacing and reducing traditional animal testing with cutting-edge human cell models, we are shaping a more sustainable future for medicine.

Optimize your pipeline with precision

From early drug testing to toxicity assessment,
we empower you to make informed decisions about the safety and efficacy of compounds.

Our Technology

Our organoids are created from human induced pluripotent stem cells (hiPSCs). When cultured under specific conditions, these hiPSCs transform into self-organizing complex structures that resemble the architecture and functionality of the human brain. This includes the presence of neurons, astrocytes, and, if desired, microglia.

Our Offer

Human cortical models

Faithfully mimic the human brain

Highly Scalable

Standardized cultures for high-throughput


Similar cell type ratios between organoids

Your Journey with BrainZell

Our streamlined process ensures a seamless experience from project initiation to the delivery of valuable insights.





Our team will work closely with you to understand your goals and design a customized project that suits your needs. 

We proceed with culturing the human brain organoids. Our state-of-the-art facilities ensure high reproducibility and scalability.

With the organoids ready, we administer the compound treatments as per the project design. Our robotic systems ensure precision and consistency.

We collect data on organoid viability, neural activity, and further assays that would empower your research and decision-making process according to your specification.

UIC Vinnova MedTech4Health Sting
SISP Almi Propel Capital Swelife